Q1: 2026-05-07 Earnings Summary EPS of $0.24 beats by $0.00  |  Revenue of $106.51M (158.87% Y/Y) beats by $14.41M Ironwood Pharmaceuticals, Inc. ( IRWD ) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT Company Participants Greg Martini - Senior VP, CFO & Investor Relations Thomas McCourt - CEO & Director Tammi Gaskins - Senior Vice President & Chief Commercial Officer. Michael Shetzline - Chief Medical Officer, Senior VP and Head of Research & Drug Development Conference Call Participants Mohit Bansal - Wells Fargo Securities, LLC, Research Division Katherine Wang - Jefferies LLC, Research Division Jason Butler - Citizens JMP Securities, LLC, Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Tom Rosenfeld Presentation Operator Thank you for standing by. My name is Liz and I'll be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals First Quarter 2026 Investor Update Conference Call.…